Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
Astellas Pharma Global Development, Inc.
Mark J Levis; Mehdi Hamadani; Brent Logan; Richard J Jones; Anurag K Singh; Mark Litzow; John R Wingard; Esperanza B Papadopoulos; Alexander E Perl; Robert J Soiffer; Celalettin Ustun; Masumi Ueda Oshima; Geoffrey L Uy; Edmund K Waller; Sumithra Vasu; Melhem Solh; Asmita Mishra; Lori Muffly; Hee-Je Kim; Jan-Henrik Mikesch; Yuho Najima; Masahiro Onozawa; Kirsty Thomson; Arnon Nagler; Andrew H Wei; Guido Marcucci; Nancy L Geller; Nahla Hasabou; David Delgado; Matt Rosales; Jason Hill; Stanley C Gill; Rishita Nuthethi; Denise King; Heather Wittsack; Adam Mendizabal; Steven M Devine; Mary M Horowitz; Yi-Bin Chen; BMT-CTN 1506/MORPHO Study Investigators